| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103100065A Chinese herbal medicine for treating abdominal pains caused by retained fluid cohesion due to deficiency-cold of spleen and lung |
| 05/15/2013 | CN103100032A Chinese herbal medicine for treating chest pains caused by dampness-heat of liver and gallbladder |
| 05/15/2013 | CN103100005A Chinese herbal medicine for treating costalgia caused by transformation of liver depression into fire |
| 05/15/2013 | CN103099890A Formula of traditional Chinese medicine moxibustion |
| 05/15/2013 | CN103099856A White paeony root processed product and preparation method thereof |
| 05/15/2013 | CN102076671B Triazole derivative or salt thereof |
| 05/15/2013 | CN101991589B Glycerol fructose injection and preparation method thereof |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101830896B Organic acid salt of optical isomer of penehyclidine |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101486713B Furo[2,3-h] chromene compound and use for preventing platelet aggregation |
| 05/14/2013 | US8440788 N-terminal VDAC variants and uses thereof |
| 05/14/2013 | US8440696 Method of using diketopiperazines and composition containing them |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2716369C Phenoxypropylamine compounds |
| 05/14/2013 | CA2546657C 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
| 05/14/2013 | CA2263890C Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 05/10/2013 | WO2013066795A1 Stable pharmaceutical formulations of growth factor peptides |
| 05/10/2013 | WO2013066483A1 Synergistic combinations of pi3k- and mek-inhibitors |
| 05/10/2013 | WO2013065835A1 Pharmaceutical composition for treating diabetes |
| 05/10/2013 | WO2013065712A1 Diazaspirourea derivative and pharmaceutical use thereof |
| 05/10/2013 | WO2013065383A1 Novel compound, method for producing same, and use of same |
| 05/10/2013 | WO2013064567A1 2-carboxamide cycloamino urea derivatives for use in treating vegf - dependent diseases |
| 05/10/2013 | WO2012124311A8 Novel phenylpyridine derivative and drug containing same |
| 05/10/2013 | CA2853582A1 2-carboxamide cycloamino urea derivatives for use in treating vegf - dependent diseases |
| 05/10/2013 | CA2846454A1 Synergistic combinations of pi3k- and mek-inhibitors |
| 05/09/2013 | US20130117871 Human Antibodies Derived from Immunized Xenomice |
| 05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
| 05/09/2013 | US20130116290 Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/09/2013 | US20130115288 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/09/2013 | US20130115267 Compositions and methods for reducing edema |
| 05/09/2013 | US20130115198 Hair follicle mesenchymal stem cells and use thereof |
| 05/08/2013 | EP2589658A1 Partial region polypeptide of reic/dkk-3 protein |
| 05/08/2013 | EP2589603A1 Vegf production promoter |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2589592A1 Novel nicotinamide derivatives or salts thereof |
| 05/08/2013 | EP2588119A2 Methods and compositions for enhancing stem cell mobilization |
| 05/08/2013 | CN103097393A Quinoxaline compound |
| 05/08/2013 | CN103097380A Inhibitor of casein kinase 1[delta] and casein kinase 1[epsilon] |
| 05/08/2013 | CN103097357A Pyrazole compound |
| 05/08/2013 | CN103097340A Therapeutically active compositions and their method of use |
| 05/08/2013 | CN103096928A Prophylactic or ameliorating agent for genetic diseases |
| 05/08/2013 | CN103096903A The therapeutic use of tetrathiomolybdate |
| 05/08/2013 | CN103096884A Cancer heat therapy-enhancing agent |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087040A Penicillide derivative, preparation method thereof, and medicinal purpose thereof |
| 05/08/2013 | CN103086882A Macrocyclic diterpene compounds in fruits of Euphorbia sororia, and preparation method and use thereof |
| 05/08/2013 | CN103083644A Dimeric iap inhibitors |
| 05/08/2013 | CN103083600A Chinese herbal medicine compound preparation for treating scale protrusion disease of crucian carps |
| 05/08/2013 | CN103083361A Fairy shrimp egg extract, preparation method and uses thereof |
| 05/08/2013 | CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/08/2013 | CN102046184B Cream-like O/W type emulsified composition and method for producing same |
| 05/08/2013 | CN102020638B 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 05/08/2013 | CN101983055B Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 05/08/2013 | CN101827816B Therapeutic agent for TRPV1-mediated disease |
| 05/08/2013 | CN101821236B Five-membered heterocyclic compound |
| 05/08/2013 | CN101621997B Pharmaceutical composition |
| 05/08/2013 | CN101128213B Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 05/07/2013 | USRE44205 Adenosine A2a receptor antagonists |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8436119 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 05/07/2013 | US8436018 Method for increasing the activity of lysosomal enzymes |
| 05/07/2013 | US8436017 Beta-2-adrenoreceptor agonists |
| 05/07/2013 | US8435958 Method for producing pectin hydrolysis products |
| 05/07/2013 | US8435534 Cancer immunotherapy |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/07/2013 | CA2659664C Improved radiation therapy methods |
| 05/07/2013 | CA2491131C Novel compounds as histone deacetylase inhibitors |
| 05/02/2013 | WO2013062074A1 Imidazolone derivative |
| 05/02/2013 | WO2013062071A1 Piperazine derivative and salt thereof |
| 05/02/2013 | WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013061962A1 Bicyclic compound |
| 05/02/2013 | WO2013061816A1 Novel compound contained in manuka honey and use of same |
| 05/02/2013 | WO2013061588A1 Transdermally absorbed preparation |
| 05/02/2013 | US20130108578 Apo-2 ligand variants and uses thereof |
| 05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/02/2013 | CA2853221A1 Bicyclic compound |
| 05/02/2013 | CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity |
| 05/01/2013 | EP2586772A1 Isoquinoline derivative |
| 05/01/2013 | EP2586462A1 Prophylactic or ameliorating agent for genetic diseases |
| 05/01/2013 | EP2586453A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 05/01/2013 | EP2585446A1 Compounds having trpv1 antagonistic activity and uses thereof |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
| 05/01/2013 | CN1564682B Compositions for potentiating glutatthione |
| 05/01/2013 | CN103080309A Partial region polypeptide of REIC/DKK-3 protein |
| 05/01/2013 | CN103080094A P2X4 receptor antagonist |
| 05/01/2013 | CN103080086A Prostaglandin D synthase inhibitory piperidine compounds |